Condition
Lewy Body Dementia Psychosis clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Lewy Body Dementia Psychosis clinical trials that are recruiting, at sites in 6 countries (most in Bulgaria (2), Czechia (2), France (2)). By phase: Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 6Countries
All recruiting trials (2)
-
ACP-204 extended treatment in Lewy Body Dementia psychosis
This study tests ACP-204 as a long-term treatment option for adults with Lewy Body Dementia psychosis who have completed prior ACP-204 treatment.
-
ACP-204 for psychosis in Lewy body dementia (Phase 2)
This 6-week, randomized, double-blind trial tests whether ACP-204 reduces psychosis symptoms in people aged 55–84 with Lewy body dementia.
Quick answers
How many Lewy Body Dementia Psychosis clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in Bulgaria (2 trials), Czechia (2 trials), France (2 trials), Italy (2 trials), Serbia (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.